Innovative solutions to
keep your project on course

Modeling and Simulation

With modeling and simulation, your existing data can answer important questions and result in significant savings in future studies.

Model-based drug development consists of the use of mathematical and statistical methods to:

  • understand how various dosing choices (e.g., dose, dose frequency, dosing duration) affect drug concentrations
  • clarify the relationship between drug concentration and desired or undesired pharmacodynamic responses
  • characterize the PK/PD variability of drugs and assist in understanding the clinically relevant factors contributing to variability

Nuventra has an expert team of pharmacometricians who build models to guide your future drug development decisions. Our team creates tailored model-based drug development plans, including rational selection of the most salient model for a given investigational compound and disease area.

Our Modeling and Simulation services:

Explore Our Blog

Key Hurdles in Immuno-Oncology

Immuno-oncology is an exciting but challenging subspecialty that falls underneath the umbrella of oncology research and development. Unlike more traditional…

Read More

Exposure-Response Part II: Measuring Exposure and Response

This is Part II of our exposure-response blog series. In our previous post, we introduced the FDA Guidance for Industry, “Exposure-Response…

Read More

FDA Commissioner Emphasizes the Importance of Modeling and Simulation to Increase Efficiency and Reduce Costs in Drug Development

Dr. Scott Gottlieb, FDA Commissioner, delivered a speech to the Regulatory Affairs Professional Society Conference on September 11, 2017 highlighting the importance…

Read More